Angiology
Type II endoleak natural history suggests selective intervention is a safe approach
Published in Cardiovascular Week, October 30th, 2006
A recent report from the United States notes, "The treatment of type II endoleaks remains controversial because little is known about their long-term natural history and impact on changes in aneurysm morphology. This study reviews type II endoleaks occurring in patients after endovascular abdominal aortic aneurysm repair (EVAR) at a single-institution over an 8-year period."
"All patients undergoing EVAR who had type II endoleaks documented on follow-up imaging studies at our institution between January 1997 and March 2005 were reviewed," wrote D. Silverberg...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2006-10-30)
More Articles from Cardiovascular Week
- Atherosclerosis
Atherosclerotic disease of intracranial arteries may be risk factor for Alzheimer disease - Atherosclerosis
Rupture-prone plaques occur in larger arteries and show significant accumulation, remodeling - Cardiovascular Research
Endothelial KCa 3.1 is key determinant of endothelial hyperpolarization and EDHF signaling - Abdominal Aortic Aneurysm
Data on abdominal aortic aneurysm described by researchers at University of Pittsburgh - Abdominal Aortic Aneurysm
New abdominal aortic aneurysm study findings have been published by scientists at University of Pennsylvania, Department of Surgery - Abdominal Aortic Aneurysm
Studies from Harborview Medical Center, Department of Surgery further understanding of abdominal aortic aneurysm - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
